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Article	type:	
Short	communication		
	 Objective(s):	 There	 are	 supportive	 evidences	 about	 the	 possible	 role	 of	 latent	 Toxoplasma.	 gondii	
infections	on	 the	behavior	and	neurologic	 functions,	 such	as	 increased	dopamine	 levels	 in	 the	brain.	
The	aim	of	this	study	was	to	examine	anti‐toxoplasma	activity	of	aripiprazole	that	is	an	atypical	anti‐
psychotic	drug	in	mice.	
Materials and Methods:	 Mice	 were	 randomly	 divided	 into	 four	 groups,	 including;	 control,	 vehicle,	
aripiprazole	10	mg/kg,	 and	aripiprazole	20	mg/kg.	The	mice	were	 inoculated	 intraperitoneally	with	
mice	brain	suspension	containing	 tissue	cysts.	At	 the	end	of	 second	month,	 the	number	of	cysts	was	
counted	in	smears	prepared	from	brain	homogenate	by	optical	microscope.	
Results:	 There	 was	 no	 significant	 difference	 between	 mean	 logarithms	 of	 brain	 cyst	 numbers	 of	
aripiprazole	groups	compared	with	control.	
Conclusion:	 Results	 indicate	 that	 in	 aripiprazole	 groups,	 the	 brain	 cystogenesis	 was	 not	 decrease.	
Further	study	needs	to	investigate	the	role	of	anti‐psychotic	drugs	on	T.	gondii.  
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Introduction	
Toxoplasma	 gondii	 is	 a	 cosmopolitan	 obligate	
intracellular	 protozoan	 zoonosis	 which	 infects	 warm‐
blooded	 vertebrates	 (1).	 In	 immunocompetent	 hosts,	
cellular	 invasion	 of	 proliferative	 tachyzoites	 slows	
usually	after	a	short	period	of	acute	phase	of	infection;	
afterwards,	 the	 parasite	 survives	 as	 a	 latent	 infection	
throughout	 life	 in	 tissues	 of	 hosts,	 especially	 in																
brain	without	 remarkable	 inflammation	around	 tissue	
cysts	 (2).	 The	 brain	 latent	 infections	 of	 T.	 gondii																															
are	 considered	 one	 of	 the	 probable	 causative	 agents														
of	 chronic	 neurologic	 disorders	 with	 unknown			
etiology.	 Epidemiological	 studies	 have	 shown	 that	
seroprevalence	 of	T.	 gondii	 is	 higher	 in	 patients	 with	
schizophrenia	(3)	in	comparison	to	controls.	Moreover,	
behavior	and	personality	alterations	have	attributed	to	
the	 chronic	 infections	of	T.	gondii	 (4).	 Experimentally,	
there	are	evidences	that	support	probable	role	of	latent	
T.	 gondii	 infections	 in	 behavior	 and	 neurologic	
functions,	such	as	the	increasing	of	dopamine	levels	in	
the	brain	(5).		
Evidence	shows	 that	 some	 of	anti‐psychotic	 and	
anti‐schizophrenic	drugs	have	 in	vitro	 anti‐toxoplasma	
activity.	 Valproic	 acid,	 an	 anticonvulsant	 mood‐
stabilizer	(6),	and	fluphenazine	and	thioridazine,	typical	
anti‐psychotics	 (7)	 inhibit	 replication	 of	 T.	 gondii	 RH	
strain	 tachyzoites	 in	 cell	 culture	 (8).	 Our	 aim	 in	 this	
study	was	to	investigate	in	vivo	anti‐toxoplasma	activity	
of	aripiprazole,	which	is	an	atypical	anti‐psychotic	drug.	
	
Materials	and	Methods		
Parasite	
Avirulent	 Tehran	 strain	 of	 T.	 gondii	 was	 kindly	
prepared	 by	 the	 Department	 of	 Parasitology	 and	
Mycology,	School	of	Public	Health,	Tehran	University	
of	Medical	 Sciences,	 Iran.	The	 strain	was	 isolated	 in	
Iran	 from	 the	 lymph	 node	 aspirate	 of	 a	
lymphadenopathy	patient	 (9).	Mice	were	purchased	
from	 Razi	 vaccine	 and	 serum	 research	 institute,	
Karaj,	Iran.		
	
Animals	
A	 total	 of	 62	 male	 BALB/c	 mice	 (20‐25	 g)	 were	
housed	 in	 groups	 of	 five	 per	 cage	 under	 standard	
laboratory	 conditions.	 They	 were	 kept	 at	 a	 constant	
room	temperature	(21±2	 °C)	under	a	normal	12L:12D	
regimen	with	free	access	to	food	and	water.	All	animal	
experiments	were	carried	out	in	accordance	with	the		
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Table	1.	Frequency	of	tissue	cysts	of	Toxoplasma	gondii	in	200	µl	of	brain	homogenate	in	different	treatment	groups	of	mice	
	
Mice	number	in	
each	group	
Number	of	cysts
Control Arip	(LD) Arip	(HD) Tween	80	
1 1  60 322 36 
2 10  51 39 27 
3 16  45 41 689 
4 10  31 27 50 
5 27  16 32 4 
6 2175  17 30 49 
7 37  40 31 9 
8 77  9 748 7 
9 44  6 89 15 
10 26  81 12 70 
				Mean±SEM	 	242.3±215.8	 35.6±7.7	 							137.1±73.8	 95.6±66.3	
	
Arip:	aripiprazole;	LD:	Low	dose	(10	mg/kg);	HD:	High	dose	(20	mg/kg);	Tween	80	as	vehicle	
	
	 European	 Communities	 Council	 Directive	 of	 24	
November	 1986	 (86/609/EEC)	 in	 such	 a	 way	 as	 to	
minimize	the	number	of	animals	and	their	suffering.		
	
Drugs	
Powder	 of	 aripiprazole	 (Tamin	 pharmaceutical	
investment	 company,	 Iran)	 was	 dissolved	 in	 tween	
80	and	administrated	IP	to	mice.	
	
Treatment		
Mice	 were	 randomly	 divided	 into	 four	 groups,	
including;	Control	(n=11),	tween	80	as	vehicle	(n=16),	
aripiprazole	 10	 mg/kg	 (n=17),	 and	 aripiprazole	 20	
mg/kg	(n=18).	The	mice	were	inoculated	IP	with	0.5	ml	
of	mice	brain	suspension	containing	50	tissue	cysts.		
Vehicle	and	aripiprazole	were	injected	one	day	after	
inoculation	of	parasites	and	every	other	day	for	the	first	
ten	days	and	every	 two	days	until	 the	end	of	 the	 first	
month.	Control	mice	did	not	receive	any	drugs.	
At	the	end	of	the	second	month	after	inoculation,	
the	 mice	 were	 anesthetized	 with	 intraperitoneal	
injections	 of	 ketamine/xylazine	 (60	 mg/kg	 and	 6	
mg/kg,	 respectively).	 Mice	 were	 sacrificed	 under	
anesthesia,	 and	 their	 brains	 were	 quickly	 removed.	
Then,	 brain	 homogenate	 was	 provided	 separately	
from	whole	brain	of	each	mouse	in	2	ml	of	saline.	The	
number	 of	 cysts	 was	 counted	 in	 smears	 prepared	
from	 200	 µl	 of	 brain	 homogenate	 with	 100×	 and	
400	magnifications	of	optical	microscope.	
	
Data	analysis	
For	normalizing	the	initial	data,	natural	logarithm	
transformation	was	used.	Data	analysis	was	through	
Kolmogorov‐Smirnov	 test,	 Analysis	 of	 Variance	
(ANOVA)	and	Tukey	post	hoc.	A	 level	of	P<0.05	was	
considered	significant.	
	
Results	
In	our	study,	some	of	the	mice	died	in	weeks	1–3	
after	 inoculation	 of	 brain	 suspension	 containing	
tissue	cysts.	Ten	mice	 in	each	group	were	randomly	
examined	 for	 counting	 T.	 gondii	 brain	 cysts.											
Overall,	the	cysts	were	observed	in	brains	of	all	mice;		
		
	
Figure	 1.	 Mean±SEM	 logarithm	 of	 brain	 cysts	 numbers	 of	
Toxoplasma	 gondii	 in	 200	 µl	 of	 brain	 homogenate	 in	 different	
treatment	groups	of	mice	
	
however,	 there	 was	 a	 remarkably	 intra‐group	 and	
inter‐group	variation	in	numbers	of	cysts	(Table	1).	
As	 the	 numbers	 of	 cysts	 varied,	 the	 data	 was	
normalized.	 Normalized	 data	 analysis	 showed	 no	
significant	 difference	 between	 mean±SEM	 of	 brain	
cyst	 numbers	 in	 the	 two	 doses	 of	 aripiprazole	
compared	to	the	control	and	vehicle	groups,	which	is	
shown	on	a	logarithmic	scale	in	Figure	1. 
	
Discussion		
In	our	study,	aripiprazole	had	no	inhibitory	effect	
on	brain	cystogenesis	of	T.	gondii	in	vivo.	The	results	
corresponds	 with	 results	 of	 Goodwin	 et	 al	 who	
showed	valproic	acid	 is	 ineffective	on	brain	cysts	of	
T.	 gondii	 in	 mice	 (10).	 On	 the	 other	 hand,	 these	
findings	are	inconsistent	with	in	vitro	results	of	other	
studies	 (6,	 11)	 which	 showed	 valproic	 acid	 has	 an	
inhibitory	 effect	 against	 tachyzoites	 of	 T.	 gondii	 in	
cell	 culture.	 In	 other	 studies	 of	 Goodwin	 et	 al,	
thioridazine	 and	 fluphenazine	 decreased	 proliferation	
of	T.	gondii	tachyzoites	in	vitro	(7).		
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Experimentally	 and	 clinically,	 anti‐Toxoplasma	
effect	of	anti‐psychotic	drugs	has	not	been	demonstra‐
ted	to	date.	There	is	a	main	difference	in	design	of	our	
study	 and	 Goodwin	 et	 al	 (10).	 In	 the	 present	 study,	
aripiprazole	was	injected	in	acute	phase	of	infection	in	
order	to	prevent	tissue	cystogenesis	 in	mice,	whereas,	
they	administrated	valproic	acid	orally	 in	 latent	phase	
of	 infection	 for	 elimination	 of	 the	 tissue	 cysts.	 In	 the	
acute	 phase	 of	 toxoplasma	 infection,	 the	 bradyzoites	
convert	 to	 rapidly	 dividing	 tachyzoites	 that	 are	
sensitive	 to	 the	 anti‐Toxoplasma	 drugs.	 In	 contrast,	 in	
the	 latent	 phase	 of	 infection,	 the	 proliferative	
tachyzoites	 converted	 to	 slowly	 dividing	 bradyzoites	
enclosed	by	cyst	wall,	which	can	persist	for	long‐time	in	
host	 tissue	 and	 are	 impervious	 against	 the	 anti‐
Toxoplasma	drugs.	Therefore,	evidence	obtained	in	our	
study	is	a	strong	support	for	the	results	of	the	previous	
study	 (10):	 anti‐psychotic	 drugs	 have	 no	 anti‐
Toxoplasma	 effect	 in	 vivo.	 Also,	 brain	 cystogenesis	
capacity	 of	T.	gondii	 shows	 a	 remarkable	 variation	 in	
mice	 experimentally	 infected	 with	 this	 parasite,	 as	
observed	in	the	present	study	and	others	(12).	
The	 mechanism	 of	 action	 of	 anti‐toxoplasmosis	
drugs	is	established.	But,	this	mechanism	about	anti‐
psychotic	 drugs	 is	 unclear.	 In	 this	 study,	 we	 have	
used	 aripiprazole,	 an	 atypical	 anti‐psychotic	 drug,	
which	unlike	typical	anti‐psychotic	drugs,	is	a	partial	
D2‐receptor	agonist	and	also	has	therapeutic	efficacy	
through	its	5‐HT	2A	antagonism	and	possibly	5‐HT	1A	
partial	agonism	(13).	
On	 the	 other	 hand,	 an	 increase	 in	 intracellular	
calcium	 occurs	 in	 tachyzoites	 of	 T.	 gondii	 when	 they	
attach	 to	 their	host	 cells	 and	 this	 increase	 is	 required	
for	 invasion.	Based	on	 the	results,	 it	 seems	 that	 initial	
attachment	 of	 tachyzoites	 to	 host	 cells	 is	 followed	 by	
calcium	 signaling	 (14)	 and	 this	 interaction	 was	 also	
inhibited	by	calcium	channel	blockers	(verapamil)	and	
calmodulin	 antagonists	 such	 as	 trifluoperazine	 and	
calmidazolium	 (15).	 Previously,	 it	 was	 reported	 that	
clozapine	as	a	prototype	agent	in	the	atypical	class,	was	
not	calmodulin	antagonist	and	it	is	suggested	that	some	
of	its	action	may	be	dependent	on	calmodulin‐activated	
kinase	activity	(7,	16).		
Furthermore,	 clozapine	 in	 protecting	 host	 cell	
against	tachyzoites	of	T.	gondii	was	not	effective	in	vitro	
(7).	It	 is	possible	that	aripiprazole	similar	to	clozapine	
is	 not	 antagonist	 of	 calmodulin	 to	 inhibit	 entry	 of	
tachyzoites	 to	 host	 cells.	 On	 the	 other	 hand,	 the	
mechanism	of	clozapine	and	aripiprazole	in	the	atypical	
group	 are	 not	 same.	 It	 was	 shown	 that	 the	 ratio	 of	
affinity	for	D2	receptors	to	affinity	for	5‐HT2A	receptors	
for	aripiprazole	is	medium	and	this	ratio	for	clozapine	
is	 very	 low	 (16).	 Also,	 in	 contrast	 to	 clozapine,	
aripiprazole	 as	 a	 blocker	 of	 5‐HT2A	 receptors	 could	
reduce	intracellular	Ca2+	levels	in	rat	pituitary	cell	 line	
(17).	 Thus,	 it	 seems	 that	 aripiprazole	 with	 chemical	
structure	of	dihydrocarbostyril	has	different	effects	on	
Ca2+	intracellular.		
Conclusion	
Results	 show	 that	 aripiprazole	 groups	 could	 not	
decrease	 the	 brain	 cystogenesis.	 Further	 studies	
need	 to	 clear	 the	 role	of	differently	 structured	anti‐
psychotic	drugs	in	treatment	of	T.	gondii.	
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